Comparison of Autologous Platelet Concentrates and Topical Steroids on Oral Lichen Planus: a Systematic Review and Meta-analysis

Overview

Journal BMC Oral Health

Publisher Biomed Central

Specialty Dentistry

Date 2024 Jun 8

PMID 38851685

Authors

Bita Azizi

Katayoun Katebi

Hosein Azizi

Maryam Hosseinpour Sarmadi

Affiliations

Soon will be listed here.

Abstract

Background: Oral lichen planus is a chronic and potentially malignant disorder of oral mucosa. Corticosteroids are used as first-line therapy for oral lichen planus patients; however, they have many side effects. Platelet concentrates (platelet-rich plasma and platelet-rich fibrin) are autologous bioactive materials. This systematic review investigated the effects of autologous platelet concentrates compared to topical steroids in treating symptomatic oral lichen planus patients.

Materials And Methods: A systematic literature search was performed in PubMed, Web of Science, Scopus, Embase, and Cochrane for randomized controlled trials. Preferred Reporting Items for Systematic Reviews and meta-analysis guidelines were observed for article selection. For the pooling of studies, meta-analysis using Standardized Mean Differences by random effects model was carried out to estimate summary effect sizes for the treatment of oral lichen planus.

Results: A total of six studies, incorporating 109 oral lichen planus patients, were involved. Both treatment modalities showed a statistically significant improvement in the outcome parameters (lesion size, pain score, Thongprasom score) from the baseline to the end of treatment and further to the follow-up visits. There was no significant difference in the pooled estimate SMD of pain decline in patients of the two groups (SMD = 0.17 (95% CI: -0.47 to 0.81); I = 63.6%). The SMD of Thongprasom score in patients receiving autologous platelet concentrates was lower than the corticosteroid groups, with no significant effect size (SMD= -2.88 (95% CI: -5.51 to -0.25); I = 91.7%). Therefore, there was no statistically significant difference between the autologous platelet concentrates and topical steroids regarding pain and clinical score.

Conclusion: Autologous platelet concentrates, and topical steroids decreased the size of lesions, Thongprasom scale, and pain in oral lichen planus patients, but the difference between the two treatments was not statistically significant. Thus, autologous platelet concentrates could be considered as an alternative treatment to topical steroids.

References

Miron R, Zhang Y . Autologous liquid platelet rich fibrin: A novel drug delivery system. Acta Biomater. 2018; 75:35-51. DOI: 10.1016/j.actbio.2018.05.021. View

Gupta S, Jawanda M . Oral Lichen Planus: An Update on Etiology, Pathogenesis, Clinical Presentation, Diagnosis and Management. Indian J Dermatol. 2015; 60(3):222-9. PMC: 4458931. DOI: 10.4103/0019-5154.156315. View

ElGhareeb M, Ghoneimy S, Elsayed A . Intralesional injection of platelet-rich plasma versus steroid in the treatment of oral lichen planus. J Cosmet Dermatol. 2023; 22(5):1481-1487. DOI: 10.1111/jocd.15622. View

Matias M, Meirelles D, Horta M, Silva K, Caldeira P, Aguiar M . ALDH1 immunoexpression in epithelial and stromal cells of oral lichen planus and lesions with lichenoid inflammatory infiltrate. Med Oral Patol Oral Cir Bucal. 2023; 28(6):e512-e518. PMC: 10635624. DOI: 10.4317/medoral.25861. View

Wu P, Diaz R, Borg-Stein J . Platelet-Rich Plasma. Phys Med Rehabil Clin N Am. 2016; 27(4):825-853. DOI: 10.1016/j.pmr.2016.06.002. View

Bennardo F, Liborio F, Barone S, Antonelli A, Buffone C, Fortunato L . Efficacy of platelet-rich fibrin compared with triamcinolone acetonide as injective therapy in the treatment of symptomatic oral lichen planus: a pilot study. Clin Oral Investig. 2021; 25(6):3747-3755. DOI: 10.1007/s00784-020-03702-w. View

Nosratzehi T . Oral Lichen Planus: an Overview of Potential Risk Factors, Biomarkers and Treatments. Asian Pac J Cancer Prev. 2018; 19(5):1161-1167. PMC: 6031815. DOI: 10.22034/APJCP.2018.19.5.1161. View

Peng Q, Zhang J, Ye X, Zhou G . Tumor-like microenvironment in oral lichen planus: evidence of malignant transformation?. Expert Rev Clin Immunol. 2017; 13(6):635-643. DOI: 10.1080/1744666X.2017.1295852. View

Mariani E, Pulsatelli L . Platelet Concentrates in Musculoskeletal Medicine. Int J Mol Sci. 2020; 21(4). PMC: 7072911. DOI: 10.3390/ijms21041328. View

10.

Torrejon-Moya A, Saka-Herran C, Izquierdo-Gomez K, Mari-Roig A, Estrugo-Devesa A, Lopez-Lopez J . Oral Lichen Planus and Dental Implants: Protocol and Systematic Review. J Clin Med. 2020; 9(12). PMC: 7767368. DOI: 10.3390/jcm9124127. View

11.

Tognoloni A, Bartolini D, Pepe M, Di Meo A, Porcellato I, Guidoni K . Platelets Rich Plasma Increases Antioxidant Defenses of Tenocytes via Nrf2 Signal Pathway. Int J Mol Sci. 2023; 24(17). PMC: 10488198. DOI: 10.3390/ijms241713299. View

12.

Tsushima F, Sakurai J, Uesugi A, Oikawa Y, Ohsako T, Mochizuki Y . Malignant transformation of oral lichen planus: a retrospective study of 565 Japanese patients. BMC Oral Health. 2021; 21(1):298. PMC: 8194014. DOI: 10.1186/s12903-021-01652-7. View

13.

Pinas L, Alkhraisat M, Suarez-Fernandez R, Anitua E . Biomolecules in the treatment of lichen planus refractory to corticosteroid therapy: Clinical and histopathological assessment. Ann Anat. 2018; 216:159-163. DOI: 10.1016/j.aanat.2017.12.006. View

14.

Chou T, Chang H, Wang J . Autologous platelet concentrates in maxillofacial regenerative therapy. Kaohsiung J Med Sci. 2020; 36(5):305-310. DOI: 10.1002/kjm2.12192. View

15.

Liberati A, Altman D, Tetzlaff J, Mulrow C, Gotzsche P, Ioannidis J . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009; 6(7):e1000100. PMC: 2707010. DOI: 10.1371/journal.pmed.1000100. View

16.

Lodi G, Manfredi M, Mercadante V, Murphy R, Carrozzo M . Interventions for treating oral lichen planus: corticosteroid therapies. Cochrane Database Syst Rev. 2020; 2:CD001168. PMC: 7047223. DOI: 10.1002/14651858.CD001168.pub3. View

17.

Leong X, Gopinath D, Syeed S, Veettil S, Shetty N, Menon R . Comparative Efficacy and Safety of Interventions for the Treatment of Oral Lichen Planus: A Systematic Review and Network Meta-Analysis. J Clin Med. 2023; 12(8). PMC: 10144824. DOI: 10.3390/jcm12082763. View

18.

Bennardo F, Gallelli L, Palleria C, Colosimo M, Fortunato L, De Sarro G . Can platelet-rich fibrin act as a natural carrier for antibiotics delivery? A proof-of-concept study for oral surgical procedures. BMC Oral Health. 2023; 23(1):134. PMC: 9996939. DOI: 10.1186/s12903-023-02814-5. View

19.

Thong I, Jensen M, Miro J, Tan G . The validity of pain intensity measures: what do the NRS, VAS, VRS, and FPS-R measure?. Scand J Pain. 2018; 18(1):99-107. DOI: 10.1515/sjpain-2018-0012. View

20.

Rotaru D, Chisnoiu R, Picos A, Picos A, Chisnoiu A . Treatment trends in oral lichen planus and oral lichenoid lesions (Review). Exp Ther Med. 2020; 20(6):198. PMC: 7588785. DOI: 10.3892/etm.2020.9328. View